Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Products sold online as retatrutide are not FDA-approved Lilly medicines, and the FDA has described them as unapproved new drugs
Tapping Tech to Streamline Side Effect Management Side effects are inevitable with GLP-1s, as they are with any pharmacological treatment
Accordingly, and in line with currently ongoing trials in HFpEF (ClinicalTrials.gov IDs NCT04916470 and NCT04788511), it may be relevant to consider obesity-related HFpEF as a specific (sub)phenotype, whether coexisting with type 2 diabetes or not
Semaglutide GLP-1 is an innovative medication originally developed for the treatment of type 2 diabetes and is now often used as an anti-obesity medication for long-term weight management
